MedTrace Logo

Evaluation of Articaine 4% Versus Mepivacaine 2% for Surgery of Molars Thirds: Clinical Trial.

NCT03384160 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2019-02-06

No results posted yet for this study

Summary

The extraction of third molars, a frequent treatment in clinical dental practice, can lead patients to painful symptoms during and after surgery. The dental surgeon must correctly indicate the need for extraction and also provide patients who need this treatment greater comfort and control of pain in the trans and postoperative period. Thus, it is necessary to use an effective local anesthetic favoring the factors inherent to the postoperative and achieving good treatment results.

Conditions

  • Pain
  • Teeth, Impacted

Interventions

DIAGNOSTIC_TEST

Group 1 -Pain monitor

Use of the anesthetic Mepivacaine 2% in third molar extraction and evaluation in postoperative

DIAGNOSTIC_TEST

Group 2 -Pain monitor

Use of the anesthetic Articaine 4% in third molar extraction and evaluation in postoperative

Sponsors & Collaborators

  • Prof. Dr. Fernando Vagner Raldi

    collaborator UNKNOWN

  • Paula Carolina de Almeida

    collaborator UNKNOWN

  • Universidade Estadual Paulista Júlio de Mesquita Filho

    lead OTHER

Principal Investigators

  • Michelle B Moraes, PHD · Universidade Estadual Paulista Júlio de Mesquita Filho-Unesp

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-07
Primary Completion
2018-10-30
Completion
2018-12-04

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03384160 on ClinicalTrials.gov